LOADING
Comparing Broadcom Inc (AVGO) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $2.08T | $368.4B |
| P/E Ratio | 81.3 | 102.2 |
| Forward P/E | 38.6 | 14.1 |
| PEG Ratio | 0.94 | 0.56 |
| EPS | $5.41 | $2.04 |
| Revenue Growth (YoY) | 29.5% | 12.4% |
| Profit Margin | 36.6% | 5.8% |
| Return on Equity | 33.4% | 62.3% |
| Dividend Yield | 0.60% | 3.24% |
| Beta | 1.44 | 0.30 |
| 52-Week High | $442.36 | $239.13 |
| 52-Week Low | $219.82 | $174.56 |
| Volume | -- | -- |
Broadcom Inc is the larger company by market capitalization. Broadcom Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.